Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
- DOI
- 10.1002/alz.14528
- Published
- 2025-03
- Container
- Alzheimer's & Dementia
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/alz.14528,
title = {Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease},
author = {Antoine Leuzy and Ariane Bollack and Daniela Pellegrino and Charlotte E. Teunissen and Renaud La Joie and Gil D. Rabinovici and Nicolai Franzmeier and Keith Johnson and Frederik Barkhof and Leslie M. Shaw and Alexander Arkhipenko and Suzanne E. Schindler and Lawrence S. Honig and Alexis Moscoso Rial and Michael Schöll and Henrik Zetterberg and Kaj Blennow and Oskar Hansson and Gill Farrar},
year = {2025},
journal = {Alzheimer's \& Dementia},
doi = {10.1002/alz.14528},
url = {https://doi.org/10.1002/alz.14528}
}RIS
TY - JOUR TI - Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease AU - Antoine Leuzy AU - Ariane Bollack AU - Daniela Pellegrino AU - Charlotte E. Teunissen AU - Renaud La Joie AU - Gil D. Rabinovici AU - Nicolai Franzmeier AU - Keith Johnson AU - Frederik Barkhof AU - Leslie M. Shaw AU - Alexander Arkhipenko AU - Suzanne E. Schindler AU - Lawrence S. Honig AU - Alexis Moscoso Rial AU - Michael Schöll AU - Henrik Zetterberg AU - Kaj Blennow AU - Oskar Hansson AU - Gill Farrar PY - 2025 JO - Alzheimer's & Dementia DO - 10.1002/alz.14528 UR - https://doi.org/10.1002/alz.14528 ER -
APA
Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., Joie, R. L., Rabinovici, G. D., Franzmeier, N., Johnson, K., Barkhof, F., Shaw, L. M., Arkhipenko, A., Schindler, S. E., Honig, L. S., Rial, A. M., Schöll, M., Zetterberg, H., Blennow, K., Hansson, O., & Farrar, G. (2025). Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14528
Source records
- crossref · retrieved 2026-09-26T03:39:07.917Z